Retraction

Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566

Citations (5)

5
Total Citations
5
Post-Retraction
(100.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
3 Within 1 year
1 After 2+ years
1033 Days since retraction (latest)
Paper citing Nrf2: a novel therapeutic target in fragile X synd...
Unknown Authors
Unknown Journal
Published: Jun 2020
1033 days after retraction
Paper citing Nrf2: a novel therapeutic target in fragile X synd...
Unknown Authors
Unknown Journal
Published: Nov 2018
441 days after retraction
Paper citing Nrf2: a novel therapeutic target in fragile X synd...
Unknown Authors
Unknown Journal
Published: Oct 2017
60 days after retraction
Paper citing Nrf2: a novel therapeutic target in fragile X synd...
Unknown Authors
Unknown Journal
Published: Oct 2017
47 days after retraction
Paper citing Nrf2: a novel therapeutic target in fragile X synd...
Unknown Authors
Unknown Journal
Published: Sep 2017
28 days after retraction
Quick Stats
Total Citations: 5
Years Since Retraction: 8.2 years
Open Access: Yes
Last Checked: Never
Related Papers
Sorting protein VPS33B regulates exosomal autocrine signali…
The Journal of Clinical Investigation (JCI) • 74 citations
Expression of HIF-1α in keloids and its correlation with in…
European Journal of Inflammation • 1 citations
MZF1 alleviates oxidative stress and apoptosis induced by r…
The Journal of Toxicological Sciences • 12 citations
Protective effect of metformin on rat diabetic retinopathy …
International Immunopharmacology • 38 citations